id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1991-E-0155-0008,FDA,FDA-1991-E-0155,U.S. Patent and Trademark Office - Approval of Application for U.S. Patent,Other,AAV-Approval of Application,2009-06-26T04:00:00Z,2009,6,2009-06-26T04:00:00Z,,2013-07-27T21:29:34Z,,0,0,090000648052d1ec
FDA-1991-E-0155-0007,FDA,FDA-1991-E-0155,HFY-1 to U.S. Patent and Trademark - Letter (4),Other,LET-Letter,2009-06-26T04:00:00Z,2009,6,2009-06-26T04:00:00Z,,2013-07-28T01:42:52Z,,0,0,090000648052d1e7
FDA-1991-E-0155-0006,FDA,FDA-1991-E-0155,U. S. Patent and Trademark Office to FDA - Letter (3),Other,LET-Letter,2009-06-26T04:00:00Z,2009,6,2009-06-26T04:00:00Z,,2013-07-27T21:29:34Z,,0,0,090000648052d1e4
FDA-1991-E-0155-0003,FDA,FDA-1991-E-0155,"Application  For Extension of Patent from Daiichi Seiyaku Co., Ltd.",Other,Application,2009-06-26T04:00:00Z,2009,6,2009-06-26T04:00:00Z,,2023-07-25T13:26:31Z,,0,0,090000648052d1d0
FDA-1991-E-0155-0001,FDA,FDA-1991-E-0155,Determination of Regulatory Review Period for Purposes of Patent Extension; Floxin,Notice,General Notice,2009-06-26T04:00:00Z,2009,6,2009-06-26T04:00:00Z,1991-06-18T03:59:59Z,2023-07-25T13:24:19Z,,0,0,090000648052d1e8
FDA-1991-E-0155-0002,FDA,FDA-1991-E-0155,"U.S. Patent and Trademark Office to Louis Gubinsky (Sughrue, Mion, Zinn, MacPeak & Seas) - Certificate Extending Patent Term",Rule,Certificate Extending Patent Term,2009-06-26T04:00:00Z,2009,6,2009-06-26T04:00:00Z,,2023-07-24T19:25:47Z,,0,0,090000648052d1ed
FDA-1991-E-0155-0004,FDA,FDA-1991-E-0155,Letter  from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2009-06-26T04:00:00Z,2009,6,2009-06-26T04:00:00Z,,2023-07-24T19:27:53Z,,0,0,090000648052d1da
FDA-1991-E-0155-0005,FDA,FDA-1991-E-0155,HFY-20 to U.S. Patent and Trademark Office - Letter (2),Other,LET-Letter,2009-06-26T04:00:00Z,2009,6,2009-06-26T04:00:00Z,,2013-07-27T21:29:34Z,,0,0,090000648052d1e3